NCT07226427
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07226427
Title A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group RECRUITING Springdale Arkansas 72762 United States Details
Yale University RECRUITING New Haven Connecticut 06519 United States Details
Florida Cancer Specialists & Research Institute RECRUITING Sarasota Florida 34232 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Icon Cancer Centre RECRUITING South Brisbane Queensland 4101 Australia Details
Cancer Research SA RECRUITING Aberfoyle Park 5000 Australia Details
Hospital Universitario Dexeus - Grupo Quironsalud RECRUITING Barcelona 08028 Spain Details
Clínica Universidad Navarra RECRUITING Madrid 28027 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid 28041 Spain Details
Hospital Universitario HM Sanchinarro RECRUITING Madrid 28050 Spain Details
Clínica Universidad de Navarra RECRUITING Pamplona 31008 Spain Details
Hospital Quironsalud Madrid RECRUITING Pozuelo de Alarcón 28226 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field